Media stories about Wright Medical Group N.V. (NASDAQ:WMGI) have trended positive recently, according to Accern Sentiment Analysis. The research firm scores the sentiment of press coverage by reviewing more than twenty million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Wright Medical Group N.V. earned a media sentiment score of 0.39 on Accern’s scale. Accern also gave news articles about the medical device company an impact score of 45.8390871615827 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the next several days.
These are some of the media stories that may have impacted Accern Sentiment’s scoring:
- Wright Medical Group N.V. to Present at Baird 2017 Global Healthcare Conference (finance.yahoo.com)
- Wright Medical Group N.V. to Present at Wells Fargo Healthcare Conference (feeds.benzinga.com)
- Wright Medical Group N.V. (NASDAQ:WMGI) Expected to Announce Quarterly Sales of $174.71 Million (americanbankingnews.com)
- IHS Markit Score Update: Rise in demand for ETFs holding Wright Medical Group NV is a positive for its shares (finance.yahoo.com)
Shares of Wright Medical Group N.V. (NASDAQ:WMGI) opened at 28.72 on Friday. The company’s market cap is $3.00 billion. The stock has a 50 day moving average price of $27.47 and a 200-day moving average price of $28.06. Wright Medical Group N.V. has a 1-year low of $20.50 and a 1-year high of $31.53.
Several equities analysts have recently weighed in on WMGI shares. BMO Capital Markets reiterated a “buy” rating and issued a $34.00 price target on shares of Wright Medical Group N.V. in a research report on Thursday, May 4th. Jefferies Group LLC boosted their target price on Wright Medical Group N.V. from $30.00 to $33.00 and gave the stock a “buy” rating in a research report on Thursday, May 4th. Oppenheimer Holdings, Inc. set a $29.00 target price on Wright Medical Group N.V. and gave the stock a “hold” rating in a research report on Thursday, May 4th. Cantor Fitzgerald initiated coverage on Wright Medical Group N.V. in a research report on Thursday, June 29th. They set an “overweight” rating and a $33.00 target price for the company. Finally, ValuEngine upgraded Wright Medical Group N.V. from a “sell” rating to a “hold” rating in a research report on Friday, June 2nd. Six equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the company. Wright Medical Group N.V. currently has a consensus rating of “Buy” and a consensus target price of $32.25.
In other Wright Medical Group N.V. news, insider Lance A. Berry sold 6,685 shares of the stock in a transaction that occurred on Friday, June 2nd. The shares were sold at an average price of $27.14, for a total transaction of $181,430.90. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, SVP Jennifer S. Walker sold 20,000 shares of the stock in a transaction that occurred on Wednesday, July 19th. The stock was sold at an average price of $28.00, for a total transaction of $560,000.00. The disclosure for this sale can be found here. Insiders have sold 40,655 shares of company stock valued at $1,116,708 in the last three months. Corporate insiders own 9.30% of the company’s stock.
Wright Medical Group N.V. Company Profile
Wright Medical Group, Inc is a global specialty orthopaedic company. The Company through Wright Medical Technology, Inc (WMT) and other subsidiaries provides extremity and biologic solutions that enable clinicians to alleviate pain and restore the patients’ lifestyles. The Company operates through three segments: U.S., International and BioMimetic.
What are top analysts saying about Wright Medical Group N.V.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Wright Medical Group N.V. and related companies.